We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,777 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2018 08:37 | yes Horlicks sale will see the £17 broken, then will need to push on. | blueteam | |
22/8/2018 16:38 | Glaxo looking very solid, good base, 17.20 in a couple of months...especially if can secure good price for Horlicks. When you look at all the total rubbish in the ftse 100, builders and such like, stands out like a beacon. | porsche1945 | |
22/8/2018 10:53 | "Still no news from USA. I thought Trump was going to make an announcement on healthcare ?" Yep very overdue Whatsup Perhaps some distractions , legal side, responsible? | fangorn2 | |
21/8/2018 21:16 | Still no news from USA. I thought Trump was going to make an announcement on healthcare ? | whatsup32 | |
21/8/2018 19:07 | Fangorn - they may do; very disruptive though to the remaining business as the sold bits are 'unpicked'. | alphorn | |
21/8/2018 19:04 | That was disappointing …. not a very 'defensive' day today, was it? | tradermichael | |
21/8/2018 17:03 | I hold roughly the same amount of RB as I do GSK. Not too certain that I would come out as a winner. | dr biotech | |
21/8/2018 16:22 | @Alphorn, Nah, it doesn't. Might possibly get more if they split it. Who knows tbh | fangorn2 | |
21/8/2018 15:05 | Fangorn - doesn't look as though they want the whole lot? (Extended my long position today). | alphorn | |
21/8/2018 15:01 | Kellogg and Reckitt Benckiser eyeing Glaxo's consumer unit | fangorn2 | |
21/8/2018 09:44 | Magnet to 1720p, in an up channel, so far so good. | ny boy | |
20/8/2018 09:29 | Two bits of news... "British drugmaker GlaxoSmithKline Pharmaceuticals is working on a strategy to reduce the number of brands in India to around 20 from 130, and bring in more patented products from the parent to the country,according to Business Standard Phama Stock Makes the Cut One firm with a juicy yield MacDonald does like is drugmaker GlaxoSmithKline (GSK). “Historically, it just had a really good yield going for it; now we think there’s a bit more of an investment case,” she says. That investment case is predicated on a new management team and a plan to restructure the Zovirax manufacturer. New boss Emma Walmsley is a plus, but it’s the “high-quality hire” of Hal Barron as chief science officer that is the big pull for MacDonald. Barron has held senior positions at Genentech, Roche and Calico and is now in charge of research and development. MacDonald says: “He is already working through their pipeline to make it more efficient and focused.” Meanwhile, his expertise in oncology, which Glaxo exited from in recent years, could signal a u-turn on that strategy. MacDonald says this would be an interesting development. Elsewhere, the vaccines and consumer health businesses are doing well. “In time, we think all this might begin to come through in a bit more growth, which has obviously been a problem,” continues MacDonald. | fangorn2 | |
18/8/2018 16:40 | waiting to see if he gets a bung. | glasgow13 | |
18/8/2018 16:32 | Thx Fangorn. We shall have to wait. ;) | alphorn | |
18/8/2018 15:16 | Vis trump drug pricing announcement. It was due week just passed. Can only find this Drug prices: Investors are still waiting on President Trump's announcement on prescription drug prices. Ahead of the drug pricing plan reveeal, Express Scripts (NASDAQ:ESRX), Humana (NYSE:HUM), MedImpact, Optum RX and Prime Therapeutics say they have not received commitments from drug manufacturers to lower drug prices. So it's still imminent! | fangorn2 | |
18/8/2018 09:37 | And 3 of the last 4 times it broke £16 it made £17 and the other it stopped just short. No guarantee it will this time but very little resistance between here and there. | tim 3 | |
18/8/2018 09:32 | Care to explain doohoma3 or abdulla | whatsup32 | |
17/8/2018 21:31 | 12 month closing high :-) | philanderer | |
17/8/2018 18:43 | I think abdulla morphed into whatsup 32 also filtered | doohoma3 | |
17/8/2018 18:25 | The very welcome dividend (ignoring the special) has been 80p for 4 years now. I am contemplating a small rise after February next year (one lives in hope):-) | sicker | |
17/8/2018 17:13 | Thanks TM . And the very best to you Sir | whatsup32 | |
17/8/2018 16:52 | Well done! | tradermichael | |
17/8/2018 16:48 | I closed my position with a decent profit today. Very happy with GSK not so much with markets. Good luck to holders | whatsup32 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions